Tema ETFs’s Cogent Biosciences COGT Stock Holding History

Tema ETFs’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.35M	Buy	241,565 +64,898	+37%	+$2.27M	0.3%	76
2026 Q1	$6.8M	Buy	176,667 +70,338	+66%	+$2.6M	0.46%	64
2025 Q4	$3.78M	Buy	106,329 +16,406	+18%	+$461K	0.29%	96
2025 Q3	$1.29M	Sell	89,923 -27,716	-24%	-$328K	0.11%	214
2025 Q2	$845K	Buy	117,639 +46,076	+64%	+$255K	0.22%	114
2025 Q1	$429K	Buy	71,563 +19,637	+38%	+$154K	0.13%	120
2024 Q4	$405K	Buy	+51,926	New	+$518K	0.17%	112

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Tema ETFs's COGT Position: Q2 2026 in Review

Tema ETFs increased its Cogent Biosciences (COGT) stake by 37% in Q2 2026, buying an estimated $2.27M and bringing the position to 241,565 shares worth $9.35M. The position accounts for 0.3% of the portfolio, ranked #76.

Tema ETFs first reported a position in COGT in Q4 2024 and has held it in 7 quarters since. 322 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

Tema ETFs held 241,565 shares of Cogent Biosciences worth $9.35M as of Q2 2026.
Tema ETFs bought 64,898 Cogent Biosciences shares in Q2 2026, an estimated $2.27M.
Cogent Biosciences made up 0.3% of Tema ETFs's portfolio in Q2 2026, its #76 holding.
Tema ETFs first reported a position in Cogent Biosciences in Q4 2024 and has held it in 7 quarters since.
322 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.